Prediction of the Most Probable B Cell Epitopes from (DnaK) Adhesin of Mycobacterium tuberculosis Using Immunoinformatic tools

  • Ghanem MtimetEmail author
  • Mouna Stayoussef
  • Besma Yacoubi-Loueslati


Tuberculosis is a contagious bacterial infection disease caused by the Koch bacillus (Mycobacterium tuberculosis: M.tb) that usually attacks the lungs, but sometimes also other parts of the body. This disease has been on the rise for some 15 years. Bacille Calmette-Guérin (BCG) is currently the only vaccine used to protect against tuberculosis. It is very useful in preventing severe disease in young children, but it does not protect reliably adult and immunodeficiency patients. So, the development of a safe vaccine that is more effective than BCG in eradicating tuberculosis in adults is a major goal of the public health. In view that infection caused by M.tb has proved recently to stimulate strongly the humoral immunity against adhesin such as (hsp70). Therefore, the aim of our study is the using of the immunoinformatic tools to predict the best linear B cell epitopes from “DnaK” adhesin (hsp70). Three best potential linear B cell epitopes (“DKGEKEQRILVFDL”, “AKIELSSSQSTSINLPYIT” and “HPGGEPGGAHPG”) were found to fulfill all the criteria for becoming an ideal B cell epitope. In addition the safety of these epitopes was evaluated using in silico techniques. In order to verify the binding cleft interaction between the selected epitopes and the antibody we used a docking method. Our computational study allows us to predict and design three novel epitope-based vaccines or which in another target could be used in diagnosis of M.tb infection.


Tuberculosis Mycobacterium tuberculosis DnaK adhesin Immunoinformatic B cell epitopes Epitope-based vaccine 


Compliance with Ethical Standards

Conflict of interest

The authors declare no conflict of interest.


  1. Achkar JM, Casadevall A (2013) Antibody-mediated immunity against tuberculosis: implications for vaccine development. Cell Host Microbe 13:250–262CrossRefGoogle Scholar
  2. Achkar JM, Chan J, Casadevall A (2014) Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis. Perspect Med 5(3):e5Google Scholar
  3. Baassi L, Sadki K, Seghrouchni F et al (2009) Evaluation of a multi-antigen test based on B-cell epitope peptides for the serodiagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis 13:848–854Google Scholar
  4. Berredo-Pinho M, Kalume DE, Correa PR et al (2011) Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M bovis BCG Pasteur. BMC Microbiol 11:80CrossRefGoogle Scholar
  5. Chou PY, Fasman GD (1978) Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol 47:145–148Google Scholar
  6. Comeau SR, Gatchell DW, Vajda S, Camacho CJ (2004) ClusPro: a fully automated algorithm for protein–protein docking. Nucleic Acids Res 32:96–99CrossRefGoogle Scholar
  7. DeGroot AS, Martin W (2003) From immunome to vaccine, epitope mapping and vaccine design tools. In: Novartis Foundation. Immunoinformatics, bioinformatic strategies for better understanding of immune function. Novartis Found Symp, p 254Google Scholar
  8. DeGroot AS, Sbai H, Aubin CS, McMurry J, Martin W (2002) Immuno-informatics: mining genomes for vaccine components. Immunol Cell Biol 80:255–269CrossRefGoogle Scholar
  9. DeGroot AS, Moise L, Liu R et al (2014) Immune camouflage: relevance to vaccines and human immunology. Hum Vaccin Immunother 10:3570–3575CrossRefGoogle Scholar
  10. Doytchinova IA, Flower DR (2007) VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform 8:4CrossRefGoogle Scholar
  11. El-Manzalawy Y, Dobbs D, Honavar V (2008) Predicting linear B-cell epitopes using string Kernels. J Mol Recognit 21:243–255CrossRefGoogle Scholar
  12. Encinales L, Zuñiga J, Granados-Montiel J et al (2010) Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis. Mol Immunol 47:1066–1073CrossRefGoogle Scholar
  13. Evans TG, Schrager L, Thole J (2016) Status of vaccine research and development of vaccines for tuberculosis. Vaccine 34:2911–2914CrossRefGoogle Scholar
  14. Fieser TM, John A, Tainer H, Houghten RA, Lerner RA (1987) Influence of protein flexibility and peptide conformation on reactivity of monoclonal anti-peptide antibodies with a protein a helix. Proc Natl Acad Sci USA 84:8568–8572CrossRefGoogle Scholar
  15. Govender VS, Ramsugit S, Pillay M (2014) Mycobacterium tuberculosis adhesins: potential biomarkers as anti-tuberculosis therapeutic and diagnostic targets. Microbiology 160:1821–1831CrossRefGoogle Scholar
  16. Gregory SH, Mott S, Phung J (2009) Epitope-based vaccination against pneumonic tularemia. Vaccine 27:5299–5306CrossRefGoogle Scholar
  17. Guirado E, Amat I, Gil O et al (2006) Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice. Microbes Infect 8:1252–1259CrossRefGoogle Scholar
  18. Gupta S, Ansari HR, Gautam A (2013) Identification of B-cell epitopes in an antigen for inducing specific class of antibodies. Biol Direct 8:27CrossRefGoogle Scholar
  19. Gutierrez MC, Brisse S, Brosch R et al (2005) Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog 1:e5CrossRefGoogle Scholar
  20. He Y, Rappuoli R, De Groot AS, Chen RT (2010) Emerging vaccine informatics. J Biomed Biotechnol 2010:218590Google Scholar
  21. Hickey TB, Thorson LM, Speert DP, Daffe M, Stokes RW (2009) Mycobacterium tuberculosis Cpn60.2 and DnaK are located on the bacterial surface, where Cpn60.2 facilitates efficient bacterial association with macrophages. Infect Immun 77:3389–3401CrossRefGoogle Scholar
  22. Karplus PA, Schulz GE (1985) Prediction of chain flexibility in proteins. Sci Nat 72:212–213CrossRefGoogle Scholar
  23. Kozakov D, Hall DR, Xia B et al (2017) The ClusPro web server for protein-protein docking. Nat Protoc 12:255–278CrossRefGoogle Scholar
  24. Larsen JE, Lund O, Nielsen M (2006) Improved method for predicting linear B-cell epitopes. Immunome Res 2:2CrossRefGoogle Scholar
  25. Leblanc P, Moise L, Luza C et al (2014) VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever. Hum Vaccin Immunother 10:3022–3038CrossRefGoogle Scholar
  26. Moise L, Gutierrez A, Kibria F et al (2015) iVAX: an integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines. Hum Vaccin Immunother 11:2312–2321CrossRefGoogle Scholar
  27. Muh HC, Tong JC, Tammi MT (2009) AllerHunter: a SVM-pairwise system for assessment of allergenicity and allergic cross-reactivity in proteins. PLoS ONE 4:6CrossRefGoogle Scholar
  28. Oyarzun P, Ellis J, Gonzalez-Galarza FF et al (2015) Bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases. Vaccine 10:1267–1273CrossRefGoogle Scholar
  29. Parker JM, Guo D, Hodges RS (1986) New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 23:5425–5432CrossRefGoogle Scholar
  30. Petrovsky N, Brusic V (2002) Computational immunology, the coming of age. Immunol Cell Biol 80:248–254CrossRefGoogle Scholar
  31. Qany AR, Emran AA, Jyoti TP (2014) Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach. Drug Des Dev Ther 8:1139–1149Google Scholar
  32. Rao M, Valentini D, Poiret T et al (2015) B in TB: B cells as mediators of clinically relevant immune responses in tuberculosis. Clin Infect Dis 61:S225–S234CrossRefGoogle Scholar
  33. Saha S, Raghava GPS (2006) Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 65:40–48CrossRefGoogle Scholar
  34. Shen Y, Maupetit J, Derreumaux P, Tufféry P (2014) Improved PEP-FOLD approach for peptide and miniprotein structure prediction. J Chem Theory Comput 14:4745–4758CrossRefGoogle Scholar
  35. Spiering R, van der Zee R, Wagenaar J, van Eden W, Broere F (2013) Mycobacterial and mouse HSP70 have immuno-modulatory effects on dendritic cells. Cell Stress Chaperones 18:439–446CrossRefGoogle Scholar
  36. Stewart GR, Snewin VA, Walzl G et al (2001) Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection. Nat Med 7:732–737CrossRefGoogle Scholar
  37. Styblo K, Meijer J, Sutherland I (1969) Tuberculosis surveillance research unit report no. 1: the transmission of tubercle bacilli its trend in a human population. Bull Int Union Tuberc 42:100–104Google Scholar
  38. Young DB (1990) The immune response to mycobacterial heat shock proteins. Autoimmunity 7:237–244CrossRefGoogle Scholar
  39. Young DB, Garbe TR (1991) Heat shock proteins and antigens of Mycobacterium tuberculosis. Infect Immun 59:3086–3093Google Scholar
  40. Zignolt M, van Gemert W, Falzon D et al (2012) Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010. Bull World Health Oragan 90:111–119CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  • Ghanem Mtimet
    • 1
    Email author
  • Mouna Stayoussef
    • 1
  • Besma Yacoubi-Loueslati
    • 1
  1. 1.Laboratory of Mycology, Pathologies and Biomarkers (LR16ES05), Department of Biology, Faculty of Sciences of TunisTunis El Manar UniversityTunisTunisia

Personalised recommendations